Sporadic Reports of Malaria, Then “Breakthrough” Announcement of Vaccine
Could health “scare” news reports be manipulated to juice the mRNA business?
As an internal medicine physician and cardiologist I am in tune to diseases seen and presented at “morning report” at big academic medical centers.
I can tell you over the decades each year there are a few cases of malaria. Travel history and contact tracing are never precise enough to declare where it came from.
Malaria gives us a chance to talk about the characteristic life cycle of organism (plasmodium species), the mosquito vector, use of diagnostic testing including the blood smear etc.
So I was suspicious a few days ago when I heard about malaria in the U.S. as making a “comeback” and some patients asking me about bug spray.
Now I see why there could be a manufactured interest in the age-old illness that is well treated with medications—a mRNA vaccine.
Alexa Cook at NewsHub is reporting:
“A team of researchers from Victoria University of Wellington’s Ferrier Research Institute, the Malaghan Institute and the Peter Doherty Institute for Infection and Immunity in Australia have developed an mRNA-based vaccine that can effectively target and stimulate protective immune cell responses against the malaria-causing parasite.”
The timing of these events is uncanny. The only reason why a few cases of malaria which are always around would make the news would be an announcement of a new therapy or vaccine.
So next time you hear about an old disease making a comeback, look for some new profitable drug or vaccine on the horizon and be suspicious of a false medical scare to juice up investor interest.
See more here substack.com
Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method
PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company 
incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX.
Trackback from your site.